HighTower Advisors’s Pfizer PFE Stock Holding History

HighTower Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,000	Closed	-$5.18K	–	3969
2024 Q4	$5.18K	Buy	+8,000	New	+$217K	﹤0.01%	3626
2024 Q3	–	Sell	-1,600	Closed	-$1.38K	–	3910
2024 Q2	$1.38K	Buy	1,600 +600	+60%	+$16.5K	﹤0.01%	3552
2024 Q1	$1.95K	Buy	+1,000	New	+$27.7K	﹤0.01%	3480
2023 Q2	–	Sell	-4,200	Closed	-$5.57K	–	3622
2023 Q1	$5.57K	Buy	+4,200	New	+$181K	﹤0.01%	3230
2022 Q3	–	Sell	-200	Closed	-$2K	–	3334
2022 Q2	$2K	Sell	200 -142	-42%	-$7.24K	﹤0.01%	3166
2022 Q1	$112K	Buy	+342	New	+$17.7K	﹤0.01%	2968
2021 Q1	–	Sell	-70	Closed	-$11K	–	3214
2020 Q4	$11K	Sell	70 -62,432	-100%	-$2.29M	﹤0.01%	2514
2020 Q3	$40K	Buy	62,502 +18,023	+41%	+$632K	﹤0.01%	2319
2020 Q2	$24K	Buy	+44,479	New	+$1.51M	﹤0.01%	2243
2020 Q1	–	Sell	-27,404	Closed	-$12K	–	2425
2019 Q4	$12K	Buy	+27,404	New	+$976K	﹤0.01%	2195
2019 Q2	–	Sell	-1,054	Closed	-$1K	–	2478
2019 Q1	$1K	Buy	+1,054	New	+$42.2K	﹤0.01%	2282
2014 Q2	–	Sell	-527	Closed	-$1K	–	1686
2014 Q1	$1K	Buy	+527	New	+$15.7K	﹤0.01%	1578

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

HighTower Advisors's PFE Position: Q1 2026 in Review

HighTower Advisors increased its Pfizer (PFE) stake by 1.4% in Q1 2026, buying an estimated $973K and bringing the position to 2,648,143 shares worth $74.4M. The position accounts for 0.08% of the portfolio, ranked #250.

HighTower Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $236M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

HighTower Advisors held 2,648,143 shares of Pfizer worth $74.4M as of Q1 2026.
HighTower Advisors bought 36,533 Pfizer shares in Q1 2026, an estimated $973K.
Pfizer made up 0.08% of HighTower Advisors's portfolio in Q1 2026, its #250 holding.
HighTower Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
HighTower Advisors's Pfizer position peaked at $236M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.